Directory · US
Biotechnology in United States
A register of firms and the professionals working at them in the Biotechnology sector based in United States. Browse the public index, then filter or export on Kipplo.
Companies
2.7K on file
Innovative Research
Innovative Research was established in 1998 after the realization that dependable, high-quality, and affordable research materials were hard to come by. Starting with core products like human plasma and serum, Innovative Research has grown to be a trusted supplier of all lab reagents, including human biologicals and ELISA kits. Today, we manufacture and supply over high-quality human and animal biologicals including plasma, serum, tissues, and proteins. In 2007, we constructed and moved into our state-of-the art facility in Novi, Michigan to accommodate our growing product line.
11 to 50 staff
Integra Companies Now Avantor Fluid Handling
Integra Companies is now Avantor Fluid Handling. Avantor’s single-use and fluid handling capabilities are built on a foundation of customer and product excellence established by Integra Companies for over 40 years. Offering high purity hose and gaskets, single-use process systems, tanks, mixers and more, our solutions and commitment to service are unsurpassed, backed by superior product knowledge and quality engineering processes.
11 to 50 staff
Invitrx Therapeutics
Invitrx Therapeutics, Inc. is a biotechnology company specializing in the culture and engineering of adult stem cells by which we develop innovative products and therapies that are used in aesthetics, wound closure, and healing as well as plastic and reconstructive surgery. Invitrx was founded in July 2003 by Habib Torfi following many years of research and clinical trials involving adult stem cell technology. The research was originally developed to treat patients suffering from burns, diabetic ulcers, ocular surface disorders, and other ophthalmic conditions. Methods were developed to harvest and concentrate stem cells, providing the bases for Invitrx's cytokine and growth factor technology that demonstrated remarkable results in anti-aging by reducing the appearance of blemishes, fine lines, and wrinkles. Thus, using Invitrx stem cell core technologies, the ReLuma skin, hair, and lash therapy product line was created. ReLuma cosmetic products were designed utilizing adult stem cell technology to rejuvenate and reactivate dormant cells. The entire line of ReLuma products, including hair care, are formulated with human adult stem cell conditioned media containing cytokines and growth factors (along with interleukins and matrix proteins) to help reduce signs of aging and promote a youthful, even-toned glow.
11 to 50 staff
Kpl Part Of Lgc Clinical Diagnostics
LGC Clinical Diagnostics’ KPL portfolio includes a range of over 800 reagents and kits for immunoassays, immunohistochemistry, infectivity assays and flow cytometry. KPL reagents include the unique BacTrace® range of native antigens and polyclonal antibodies for bacterial pathogens, secondary antibodies, substrates, washing buffers and more. All KPL reagents are designed for optimal signal:noise ratios in order to maximise sensitivity and specificity across applications.
51 to 200 staff
Lifeline Cell Technology
Lifeline Cell Technology® (Lifeline) develops, manufactures, and markets the highest quality normal human cells, cell culture media, and reagents for the research marketplace. We take pride in our customer and technical service and will work diligently to assist you with your cell culture requirements. Lifeline is a wholly owned subsidiary of International Stem Cell Corporation,(ISC)(ISCO.OB), a public stem cell therapeutics company based in Oceanside, CA. Lifeline’s production and administrative facilities are located in Frederick, MD. Lifeline’s customers are scientists working in major research organizations such as pharmaceutical companies, academic and government institutions. Lifeline’s specialized products for the culture of normal human cells eliminate the need for each scientist to create his or her own media and reagents or try to adapt “off the shelf” products to the specialized world of human stem cell research. Our modern laboratories and strict quality assurance provide the highest level of consistent value to the research community.
11 to 50 staff
Luminopia
Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com. Please see Luminopia Directions For Use for more information: luminopia.com/dfu
11 to 50 staff
Mirvie
Mirvie is the 1st to predict pregnancy complications before they happen by using RNA messages to reveal underlying biology of pregnancy health. Using a simple blood test, the platform reveals vital information about a pregnancy’s unique biology that drives changes throughout pregnancy. The result? The power to transform how we predict, prevent and treat unexpected complications.
11 to 50 staff
Molecular Designs
Molecular Designs is a team of doctors and scientists working to advance molecular diagnostics. Our founding physicians entered the molecular diagnostics market focused on the most common pathogens that impact the population – making products that were cost-effective, reduced waste, and easy to use. Our mission is to empower providers and researchers with the molecular insights needed to deliver exceptional patient care. We do this by developing, producing, and supplying multiplex assays for research use. We believe we can make the world a healthier place by improving the delivery and use of molecular technologies. As a physician-founded company, we’re passionate about helping people, sharing our expertise, and improving healthcare outcomes. It is a privilege to do the work we do – and we have built an exceptional reputation as problem-solvers with an unwavering commitment to integrity. With locations in Alabama and Texas, and remote workers nationwide, we continue to seek top talent to support our growth, develop new molecular diagnostics, and better serve our customers. Our suite of employee benefits includes medical, dental, and vision insurance. And our 401K plan with company match program, paid time off, extensive voluntary benefits, and staff appreciation programs make Molecular Designs an employee-first organization.
51 to 200 staff
Nanosyn
Nanosyn, provider of Chemistry on Demand services, is a medicinal chemistry based organization providing made-to-order focused compound libraries, hit-to-lead optimization, medicinal chemistry services and other innovative solutions to meet your drug discovery needs. Our proprietary technology allows us to provide superior chemistry services that effectively accelerate the drug discovery process for biotechnology and pharmaceutical companies worldwide since 1998. For our biology services, please visit http://nanosyn.bio/.
51 to 200 staff
Nephros
Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency solutions for water management.
11 to 50 staff
Novogene America
Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 45 NGS-related patents, as well as over 950 SCI articles with a total impact factor of more than 7970, including publications in first tiers journals such as Cell, Nature and Science. The UC Davis location of Novogene Corporation Inc. was opened in early 2016. We utilize Illumina platform to serve customers in North and South America, and we also offer PacBio and Nanopore services. Novogene Corporation Inc. is proud to have collaborated with scientists from the USA, Canada, Brazil, Colombia, Mexico, and so many more. We are excited to see this global collaboration and partnership growing.
501 to 1000 staff
Onyx Pharmaceuticals, Inc., An Amgen Subsidiary
Formerly based in South San Francisco, California, Onyx Pharmaceuticals was engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. Amgen acquired Onyx Pharmaceuticals in 2013. See our Community Guidelines: bit.ly/smcgl
501 to 1000 staff
Orchard Therapeutics - U.S
Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on ending the devastation caused by genetic and other severe diseases by discovering, developing, and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease with a single treatment. Founded in 2015, Orchard’s roots go back to some of the first research and clinical developments involving HSC gene therapy. Our team has played a central role in the evolution of this technology from a promising scientific idea to a potentially life-transforming reality. Today, Orchard is advancing a pipeline of HSC gene therapies designed to address serious diseases where the burden is immense for patients, families and society and current treatment options are limited or do not exist. For more information, please visit
51 to 200 staff
Pathosans , From Spraying Systems Co
PathoSans, a division of Spraying Systems Company is a leader in the development of innovative, efficient & environmentally responsible cleaning technology. We utilize advanced electrolytic technology to generate neutral, acidic and basic cleaning solutions. These solutions are highly effective and can be generated on-site and on-demand. PathoSans systems have the most efficient production to cost ratio in the industry. We have numerous patents and patents pending and are continually developing new products to reduce carbon footprint, increase worker safety and reduce costs.
11 to 50 staff
Pendulum Therapeutics
Pendulum Therapeutics is the leading innovator in microbiome science, delivering research based probiotic formulations to support metabolic health. The company leverages cutting-edge research and strong intellectual property to bring effective, science-backed solutions to consumers worldwide. Pendulum Akkermansia was the first novel species to be brought to the probiotics market in more than 50 years. The first and only probiotic in the world clinically proven to lower A1C and blood glucose in people with type 2 diabetes, Akkermansia stimulates natural GLP-1 production.
51 to 200 staff
Phylos
Phylos is a cannabis genetics company focused on helping growers of all sizes to succeed commercially with seeds that produce the highest quality cannabis in the most cost-effective way. Phylos supports commercial-scale cultivation with the industry’s first Production-Ready Seed™: premium, phenotypically stable, fully-feminized F1 hybrid seeds that deliver exceptional flower quality, potency, vigor, and yield. Phylos also leverages its proprietary technologies and its cultivation, extraction, and formulation expertise to provide partners with unparalleled THCV genetics and natural, safe and effective ingredients.
11 to 50 staff
Pionyr Immunotherapeutics
In 2015, Pionyr Immunotherapeutics embarked on a journey to forge a new path in immuno-oncology for patients in need. We are a clinical stage company discovering and developing novel antibody therapeutics that dramatically alter the tumor microenvironment (TME) and enhance the body’s immune defense against cancer – with the potential to eliminate it. Pionyr's Myeloid Tuning™ cutting-edge technology is based on the discovery that “tuning” the tumor microenvironment to favor immune-activating cells and disable immune-suppressing cells improves the body’s ability to combat cancer, particularly in combination with checkpoint inhibitors. Additionally, Pionyr is building a pipeline of transmembrane and intracellular targets using our cutting-edge technologies and translational assays. Immuno-oncology is a complex field, which is why Pionyr has recruited a bold and growing team with extensive experience in immunology, immuno-oncology, target discovery, and immunotherapy development. Our “Pionyrs” are banded together by innovation, integrity, team empowerment, respect and one unified voice to translate meaningful science into promising opportunities for treating cancer.
51 to 200 staff
Provident Research Inc
Provident Research Inc.(PRI) concentrates on providing Strategic Staffing, Talent Acquisition and FSP solutions to the Pharmaceutical, Biotechnology, Medical Device and CRO industries. Through our Clinical Compass division, PRI drives patient enrollment for difficult to enroll protocols or studies involving multiple competing drugs. Headquartered in Rockville, Maryland just 4 miles from the FDA, PRI has access to some of the greatest leaders in clinical development. Our team continues to involve clinical research experts from the very companies and segments we call Clients today. Our management team, talent recruiters, talent mangers and professional services staff are decorated veterans of the pharma, biotech and medical device industry with the unique perspective of having “been there. done that.” Many members of our professional team has worked within the industry as CRAs, CRA Line Managers, Clinical Project and Operations Managers, Medical Science Liaisons and Human Resource partners. This experience translates into a very clear understanding your needs, timelines and requirements. At PRI, the experiences we deliver begin with a culture that is based on a passionate spirit of doing good things for others. Specializing in Staffing, Talent Acquisition and Strategic Clinical Consulting through our Clinical Compass division, we’re built to deliver consistent results. We promise to create remarkable experiences.
201 to 500 staff
Quralis
At QurAlis, we are neuro pioneers on a quest to cure, boldly seeking to translate scientific breakthroughs into powerful precision medicines. We work collaboratively with a relentless pursuit of knowledge, precise attention to craft, and compassion to discover and develop medicines that have the potential to transform the lives of people living with neurodegenerative and neurological diseases. QurAlis is the leader in development of precision therapies for amyotrophic lateral sclerosis (ALS). In addition to ALS, QurAlis is advancing a robust precision medicine pipeline to bring effective disease-modifying therapeutics to patients suffering from severe diseases defined by genetics and clinical biomarkers.
51 to 200 staff
Rani Therapeutics
Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs. Millions of patients with chronic conditions require biologic drugs, the vast majority of which must be injected. We have developed the RaniPill™ technology to replace subcutaneous or IV injections of biologics with an oral pill. The RaniPill™ capsule is designed to deliver an injection to the intestinal wall, where there are no sharp pain receptors, and has achieved bioavailability similar to subcutaneous injections. We believe oral versions of biologics will have the potential to transform medicine and improve outcomes for the millions of patients who currently rely on chronic self-injections.
51 to 200 staff
Renmatix
We unlock the building blocks created by nature within biomass. Using Plantrose(R) technology, we transform biomass into unique materials that enable the production of SAF and lower carbon materials (e.g. natural polyols) solving high U.S. demand for decarbonization, climate change, and bio-based products. Our platform Plantrose® technology is the key to releasing unique ingredients from plants. When it comes to the products we rely on to nourish and care for our bodies, the way we make the ingredients, matters a lot. That’s why the Plantrose platform, is an incredible breakthrough. Only using water, we transform the plants into new and unique ingredients. These ingredients have immense functionality in many applications, derived from their unique size and shape. We are proud to be a part of the emerging consumer wellness space. The world now understands that sustainability and recycling is a good start, but not the end of the story. Consumer demand now reaches further – for products that support their health and wellness but also support the wellness of the earth and industries that create their products and services. Renmatix is delivering a solution to support their choices by upcycling red maple residues to produce valuable and versatile ingredients for skin and food applications using an eco-friendly technology. So. why does this matter? Responsible use and care of Mother Nature’s bounty is in the DNA of our technology and company culture. Mother Nature makes the plants rich with an abundance of cellulose and lignin in the cell wall structure. Plantrose was born with the intent to provide valuable materials for many applications while protecting the well being of our environment, the people, and all creatures. We can serve the markets, upcycle waste streams, bring technology to rural communities, and protect our planet. The time is now to replace synthetic chemicals, with plant ingredient innovation. The wellness industry is thriving, as is Plantrose.
11 to 50 staff
Sanaria Inc
Sanaria is a biotechnology company dedicated to the production of a vaccine protective against malaria caused by the pathogen Plasmodium falciparum. Sanaria’s vaccine is based on an approach to immunization that has already proven highly protective in humans.
11 to 50 staff
Santa Cruz Biotechnology Scbt
Santa Cruz Biotechnology, Inc. seeks motivated individuals to become a part of its team. The company offers a variety of career opportunities. Santa Cruz Biotechnology provides a comfortable work environment that fosters collaborative relationships amongst goal-oriented professionals. Our Dallas, TX headquarters office is conveniently located off Interstate 35E, northwest of downtown Dallas where a variety of excellent restaurants, shopping and entertainment await. Dallas is perfect for anyone who lives an active lifestyle; trails, lakes and golf courses abound! Dallas is home to the Dallas Cowboys football team, Dallas Mavericks basketball team, Dallas Stars hockey team and FC Dallas soccer team; it is also within easy driving distance to Arlington where you can find the Texas Rangers baseball team. Will Rogers Memorial Center located in nearby Fort Worth offers frequent horse shows, rodeos, expositions and concerts. Other renowned attractions include the Dallas World Aquarium, Dallas Zoo, Perot Museum of Nature and Science, and the annual State Fair of Texas. U.S. News and World Report named fifty Dallas-Ft Worth area high schools in the America's Best High Schools List for 2015, including the #1 spot.
201 to 500 staff
Sapphire Energy Inc
San Diego-based Sapphire Energy is pioneering an approach that takes two very old processes and synthesizes them into one very new opportunity. Farming and algae have been around for most of human existence, but the two have not been paired in any significant way to bring leverage the positive effects on one another. Sapphire’s products and processes in this category differ significantly from others because they are made solely from photosynthetic microorganisms (algae and cyanobacteria), using sunlight and CO2 as their feedstock; are not dependent on food crops or valuable farmland; do not use potable water; do not result in biodiesel or ethanol; are compatible with existing infrastructure; and are low carbon, renewable and scalable. Sapphire has an R&D facility in Las Cruces, New Mexico, and has been operating a 300-acre facility continuously since May 1, 2012. Learn More at Like us on Facebook Follow us on twitter https://twitter.com/SapphireEnergy Watch our videos
51 to 200 staff
